September 18, 2014 12:58 AM ET

Biotechnology

Company Overview of Arriva Pharmaceuticals, Inc.

Company Overview

Arriva Pharmaceuticals, Inc., a biopharmaceutical company, develops anti-inflammatory therapies for treating respiratory diseases. It focuses on various therapeutic areas of hereditary emphysema; and chronic obstructive pulmonary disease, including smoking-related emphysema, cystic fibrosis, and other respiratory indications. The company’s products include Respriva, which is formulated for inhalation delivery into the deep lung using nebulizers for the treatment hereditary emphysema; Ilomastat, an inhibitor of matrix metalloproteases; and Aeriva, a fusion protein that combines secretory leukocyte protease inhibitor and recombinant alpha 1-antitrypsin. Arriva Pharmaceuticals, Inc. was formerl...

1010 Atlantic Avenue

Alameda, CA 94501

United States

Founded in 1997

Phone:

510-337-1250

Fax:

510-337-1251

Key Executives for Arriva Pharmaceuticals, Inc.

Chief Executive Officer and President
Vice President of Finance and Administration
Chief Technical Officer
Director of Corporate and Business Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Vasculox, Inc. United States
3-D Matrix, Inc. United States
Therapeutic Peptides, Inc. United States
Primogenix Inc. United States
Aixlie Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arriva Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.